The mental health consequences of the COVID-19 pandemic are likely to be vast, exceeding the capacity of mental health services and delaying treatment for people in need, with devastating consequences for those affected. Emerging data suggest that frontline health workers (e.g. physicians, nurses, EMTs) and essential workers (in industries such as energy, and food products and services) face particular risks for mental health problems during and after the COVID-19 outbreak. To address the unprecedented mental health needs during and as a result of the COVID-19 pandemic this study will develop and test novel, cost-effective and scalable, digitally-delivered mental health interventions, and will test this approach by focusing on health care workers and other essential workers.
Stigma towards mental health care is a profound obstacle that interferes with individuals seeking these services. Research suggests that interventions that are based on social contact are the most efficient way to reduce stigma. By combining online video and interactive behavioral change modules, this study aims to address stigma and both empower essential workers (healthcare and non-healthcare workers) both to seek treatment for mental health issues as well as to reduce psychiatric symptoms by increasing social support, facilitating sleep hygiene, and maintaining physical exercise. A total of 4,200 members of these high-risk groups will be recruited to participate in a randomized controlled trial (RCT) testing the efficacy of the intervention. The intervention will consist of brief videos in which empowered members of the respective high-risk group (presented by actors) share their COVID-19 related mental health problems and describe how they were able to confront their mental health problems, which in turn helped them seek mental health care. The video will be followed by a short, interactive, digital behavioral change module. Within each high-risk group, individuals will first be randomized to receive the video (one time), video plus booster (second administration of the video), or non-intervention video control. The study will randomize participants within each high-risk group into one of three arms: 1\) Video + Behavioral Change Module, with Booster: 2-3-minute video (in which empowered members of the respective high-risk group (protagonists) share their COVID-19 related mental health problems and describe how they were able to confront their mental health problems, which in turn helped them seek mental health care) will be followed by 3-4-minute online digital behavioral change modules at days 1 and 14 of the study ("video+booster"); 2) Video + Behavioral change modules without Booster: 2-3-minute video will be followed by 3-4-minute online digital behavioral change modules at day 1 only ("video"); 3) No Intervention video (Control Arm): Participants randomized to this arm will receive video not related to mental health ("control"). Following the intervention, the study includes three follow-ups (day 14, 30, and 90) to examine longer-term effects.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Enrollment
4,134
A short video (primary outcome) that aimed at reducing stigma towards treatments and increasing help seeking intentions. The behavioral change module (secondary outcome) is aimed at changing behaviors of sleep, exercise and social support.
New York State Psychiatric Institute
New York, New York, United States
Stigma (the SSOSH-3)
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Time frame: immediately after the intervention
Stigma (3 items of the SSOSH-3)
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Time frame: 14 days after the intervention
Stigma (3 items of the SSOSH-3)
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Time frame: 30 days after the intervention
Stigma (3 items of the SSOSH-3)
Change in stigma items from baseline - higher score, indicate higher stigma (range of 3 to 12)
Time frame: 90 days after the intervention
Help Seeking Intentions (3 items of the ATSPPH)
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
Time frame: Immediately after the intervention
Help Seeking Intentions (3 items of the ATSPPH)
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
Time frame: 14 days after the intervention
Help Seeking Intentions (3 items of the ATSPPH)
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
Time frame: 30 days after the intervention
Help Seeking Intentions (3 items of the ATSPPH)
Change in treatment seeking intentions from baseline - higher score, indicate higher help seeking intentions (range of 3 to 12)
Time frame: 90 days after the intervention
Behaviors questionnaire
Four questions about sleep (quality of sleep), exercise (amount of weekly exercise) and social habits (weekly number of people one contacted). We will measure change from baseline
Time frame: 14 days after the intervention
Behaviors questionnaire
Four questions about sleep (quality of sleep), exercise (amount of weekly exercise) and social habits (weekly number of people one contacted). We will measure change from baseline
Time frame: 30 days after the intervention
Behaviors questionnaire
Four questions about sleep (quality of sleep), exercise (amount of weekly exercise) and social habits (weekly number of people one contacted). We will measure change from baseline
Time frame: 90 days after the intervention
Clinical outcome - Anxiety
Change from baseline in GAD-7 (range 0-21, higher score indicate more anxiety)
Time frame: 14 days after the intervention
Clinical outcome - Anxiety
Change from baseline in GAD-7 (range 0-21, higher score indicate more anxiety)
Time frame: 30 days after the intervention
Clinical outcome - Anxiety
Change from baseline in GAD-7 (range 0-21, higher score indicate more anxiety)
Time frame: 90 days after the intervention
Clinical outcome - Depression
Change from baseline in PHQ-9 (range 0-27, higher score indicate more depression)
Time frame: 14 days after the intervention
Clinical outcome - Depression
Change from baseline in PHQ-9 (range 0-27, higher score indicate more depression)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 30 days after the intervention
Clinical outcome - Depression
Change from baseline in PHQ-9 (range 0-27, higher score indicate more depression)
Time frame: 90 days after the intervention
Clinical outcome - PTSD
Change from baseline in PC-PTSD (range 0-5, higher than 2 indicates high probability of PTSD)
Time frame: 14 days after the intervention
Clinical outcome - PTSD
Change from baseline in PC-PTSD (range 0-5, higher than 2 indicates high probability of PTSD)
Time frame: 30 days after the intervention
Clinical outcome - PTSD
Change from baseline in PC-PTSD (range 0-5, higher than 2 indicates high probability of PTSD)
Time frame: 90 days after the intervention